NasdaqGM - Nasdaq Real Time Price • USD
AtriCure, Inc. (ATRC)
As of 1:19 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | -0.23 | -0.16 | -0.74 | -0.57 |
| Low Estimate | -0.3 | -0.2 | -0.79 | -0.79 |
| High Estimate | -0.2 | -0.12 | -0.63 | -0.29 |
| Year Ago EPS | -0.23 | -0.11 | -0.66 | -0.74 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 9 |
| Avg. Estimate | 106.9M | 116.82M | 461.3M | 525.56M |
| Low Estimate | 105.4M | 115.78M | 459.6M | 517.5M |
| High Estimate | 108.67M | 118M | 463.13M | 531.5M |
| Year Ago Sales | 93.49M | -- | 399.25M | 461.3M |
| Sales Growth (year/est) | 14.30% | -- | 15.50% | 13.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.34 | -0.29 | -0.31 | -0.23 |
| EPS Actual | -0.23 | -0.11 | -0.2 | -0.21 |
| Difference | 0.11 | 0.18 | 0.11 | 0.02 |
| Surprise % | 32.40% | 62.10% | 35.50% | 8.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.23 | -0.16 | -0.74 | -0.57 |
| 7 Days Ago | -0.23 | -0.16 | -0.74 | -0.57 |
| 30 Days Ago | -0.23 | -0.16 | -0.74 | -0.57 |
| 60 Days Ago | -0.23 | -0.16 | -0.74 | -0.58 |
| 90 Days Ago | -0.2 | -0.15 | -0.69 | -0.6 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ATRC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 0.00% | -- | -- | 1.50% |
| Next Qtr. | -45.50% | -- | -- | 12.10% |
| Current Year | -12.10% | -- | -- | 4.40% |
| Next Year | 23.00% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 20.00% | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Oppenheimer: Perform to Outperform | 4/23/2024 |
| Reiterates | Needham: Buy to Buy | 4/10/2024 |
| Maintains | UBS: Buy to Buy | 2/16/2024 |
| Maintains | Stifel: Buy to Buy | 2/16/2024 |
| Maintains | Needham: Buy to Buy | 2/16/2024 |
| Maintains | Needham: Buy to Buy | 1/4/2024 |
Related Tickers
ANGO AngioDynamics, Inc.
5.79
+0.17%
STVN Stevanato Group S.p.A.
27.50
-0.09%
MMSI Merit Medical Systems, Inc.
74.08
+0.95%
EMBC Embecta Corp.
10.37
-0.29%
LMAT LeMaitre Vascular, Inc.
64.91
+3.05%
BLFS BioLife Solutions, Inc.
17.05
+1.11%
ICUI ICU Medical, Inc.
95.51
+1.04%
UTMD Utah Medical Products, Inc.
66.21
-0.12%
AZTA Azenta, Inc.
52.25
+1.46%
STXS Stereotaxis, Inc.
2.2950
-2.34%